Crispr Therapeutics AG

Organization

Basel, CH

Ticker Symbols

NASDAQ:CRSP

BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)
Business Address
BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
Mailing Address
BAARERSTRASSE 14 ZUG V8 CH-6300
State Location
V8
State of Incorporation
V8

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Materials and methods for controlling gene editing
- Patent number 12,173,290
- Issue date Dec 24, 2024
- CRISPR THERAPEUTICS AG
- Ryo Takeuchi
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Materials and methods for treatment of usher syndrome type 2A and/o...
- Patent number 12,122,998
- Issue date Oct 22, 2024
- CRISPR THERAPEUTICS AG
- Mariacarmela Allocca
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods and compositions for treating angiopoietin-like 3 (ANGPTL3)...
- Patent number 12,037,616
- Issue date Jul 16, 2024
- CRISPR THERAPEUTICS AG
- Yi-Shan Chen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Gene editing for hemophilia A with improved factor VIII expression
- Patent number 12,016,932
- Issue date Jun 25, 2024
- CRISPR THERAPEUTICS AG
- Alan Richard Brooks
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for the depletion of CD117+ cells
- Patent number 11,958,908
- Issue date Apr 16, 2024
- CRISPR THERAPEUTICS AG
- Bradley R. Pearse
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Masked chimeric antigen receptor specific to tyrosine-protein kinas...
- Patent number 11,926,676
- Issue date Mar 12, 2024
- CRISPR THERAPEUTICS AG
- Jason Sagert
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for gene editing
- Patent number 11,920,148
- Issue date Mar 5, 2024
- CRISPR THERAPEUTICS AG
- Ante Sven Lundberg
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Materials and methods for treatment of glycogen storage disease typ...
- Patent number 11,866,727
- Issue date Jan 9, 2024
- CRISPR THERAPEUTICS AG
- Chad Albert Cowan
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Genetically engineered T cells with Regnase-1 and/or TGFBRII disrup...
- Patent number 11,857,574
- Issue date Jan 2, 2024
- CRISPR THERAPEUTICS AG
- Mary-Lee Dequeant
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Materials and methods for treatment of alpha-1 antitrypsin deficiency
- Patent number 11,851,653
- Issue date Dec 26, 2023
- CRISPR THERAPEUTICS AG
- Chad Albert Cowan
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods and compositions for efficient gene deletion
- Patent number 11,833,225
- Issue date Dec 5, 2023
- CRISPR THERAPEUTICS AG
- Elizabeth Paik
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for genomic editing by insertion of donor...
- Patent number 11,827,877
- Issue date Nov 28, 2023
- CRISPR THERAPEUTICS AG
- Troy Dean Carlo
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-idiotype antibodies targeting anti-CD70 chimeric antigen receptor
- Patent number 11,795,238
- Issue date Oct 24, 2023
- CRISPR THERAPEUTICS AG
- Lalit Kumar
- G01 - MEASURING TESTING
Information Patent Grant
Genetically engineered t cells with Regnase-1 and/or TGFBRII disrup...
- Patent number 11,679,130
- Issue date Jun 20, 2023
- CRISPR THERAPEUTICS AG
- Mary-Lee Dequeant
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Genetically engineered T cells with regnase-1 and/or TGFBRII disrup...
- Patent number 11,679,131
- Issue date Jun 20, 2023
- CRISPR THERAPEUTICS AG
- Mary-Lee Dequeant
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for treating cancer
- Patent number 11,649,438
- Issue date May 16, 2023
- CRISPR THERAPEUTICS AG
- Jonathan Alexander Terrett
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Materials and methods for engineering cells and uses thereof in imm...
- Patent number 11,622,977
- Issue date Apr 11, 2023
- CRISPR THERAPEUTICS AG
- Jonathan Alexander Terrett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Gene-edited natural killer cells
- Patent number 11,591,381
- Issue date Feb 28, 2023
- CRISPR THERAPEUTICS AG
- Valentin Sluch
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Universal donor cells
- Patent number 11,578,309
- Issue date Feb 14, 2023
- CRISPR THERAPEUTICS AG
- Alireza Rezania
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
RNA-programmable endonuclease systems and their use in genome editi...
- Patent number 11,578,323
- Issue date Feb 14, 2023
- Bayer HealthCare LLC
- Andre Cohnen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Materials and methods for treatment of friedreich ataxia and other...
- Patent number 11,564,997
- Issue date Jan 31, 2023
- CRISPR THERAPEUTICS AG
- Ante Sven Lundberg
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Universal donor cells
- Patent number 11,566,230
- Issue date Jan 31, 2023
- CRISPR THERAPEUTICS AG
- Alireza Rezania
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Materials and methods for treatment of Spinocerebellar Ataxia Type...
- Patent number 11,559,588
- Issue date Jan 24, 2023
- CRISPR THERAPEUTICS AG
- Ante Sven Lundberg
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Gene editing for hemophilia A with improved factor VIII expression
- Patent number 11,529,427
- Issue date Dec 20, 2022
- CRISPR THERAPEUTICS AG
- Alan Richard Brooks
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Genetically engineered t cells with regnase-1 and/or TGFBRII disrup...
- Patent number 11,497,773
- Issue date Nov 15, 2022
- CRISPR THERAPEUTICS AG
- Mary-Lee Dequeant
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for differentiating stem cells into NK cells
- Patent number 11,473,060
- Issue date Oct 18, 2022
- CRISPR THERAPEUTICS AG
- Viktoriia Kyrychenko
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Materials and methods for engineering cells and uses thereof in imm...
- Patent number 11,471,491
- Issue date Oct 18, 2022
- CRISPR THERAPEUTICS AG
- Jonathan Alexander Terrett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Gene-edited natural killer cells
- Patent number 11,459,372
- Issue date Oct 4, 2022
- CRISPR THERAPEUTICS AG
- Valentin Sluch
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Universal donor cells
- Patent number 11,433,103
- Issue date Sep 6, 2022
- CRISPR THERAPEUTICS AG
- Alireza Rezania
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Universal donor cells
- Patent number 11,434,505
- Issue date Sep 6, 2022
- CRISPR THERAPEUTICS AG
- Alireza Rezania
- C07 - ORGANIC CHEMISTRY

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
GENE EDITING FOR HEMOPHILIA A WITH IMPROVED FACTOR VIII EXPRESSION
- Publication number 20240415981
- Publication date Dec 19, 2024
- CRISPR Therapeutics AG
- Alan Richard Brooks
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD117+ CELLS
- Publication number 20240360238
- Publication date Oct 31, 2024
- CRISPR Therapeutics AG
- Bradley R. Pearse
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MASKED CHIMERIC ANTIGEN RECEPTOR SPECIFIC TO TYROSINE-PROTEIN KINAS...
- Publication number 20240352151
- Publication date Oct 24, 2024
- CRISPR Therapeutics AG
- Jason Sagert
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR GENE EDITING
- Publication number 20240318200
- Publication date Sep 26, 2024
- CRISPR Therapeutics AG
- Ante Sven Lundberg
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MATERIALS AND METHODS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE TYP...
- Publication number 20240229078
- Publication date Jul 11, 2024
- CRISPR Therapeutics AG
- Chad Albert COWAN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MATERIALS AND METHODS FOR TREATMENT OF ALPHA-1 ANTITRYPSIN DEFICIENCY
- Publication number 20240175014
- Publication date May 30, 2024
- CRISPR Therapeutics AG
- Chad Albert COWAN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR GENE EDITING FOR HEMOPHILIA A
- Publication number 20240173434
- Publication date May 30, 2024
- CRISPR Therapeutics AG
- Alan Richard Brooks
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS FOR GENOMIC EDITING BY INSERTION OF DONOR...
- Publication number 20240167060
- Publication date May 23, 2024
- CRISPR Therapeutics AG
- Troy Dean CARLO
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GENETICALLY ENGINEERED ANTI-CD19 CAR-T CELLS FOR USE IN TREATING B-...
- Publication number 20240115703
- Publication date Apr 11, 2024
- CRISPR Therapeutics AG
- Ziliang LI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LIPID NANOPARTICLES (LNPs)-BASED OCULAR DELIVERY
- Publication number 20240041757
- Publication date Feb 8, 2024
- CRISPR Therapeutics AG
- Seshidhar Reddy Police
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MATERIALS AND METHODS FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS
- Publication number 20230392134
- Publication date Dec 7, 2023
- CRISPR Therapeutics AG
- Hari Kumar Padmanabhan
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MULTIPLEX GENE EDITED CELLS FOR CD70-DIRECTED CANCER IMMUNOTHERAPY
- Publication number 20230390392
- Publication date Dec 7, 2023
- Nkarta, Inc.
- James Barnaby Trager
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CD70+ SOLID TUMOR THERAPY USING GENETICALLY ENGINEERED T CELLS TARG...
- Publication number 20230355761
- Publication date Nov 9, 2023
- CRISPR Therapeutics AG
- Jonathan Alexander TERRETT
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GENETICALLY ENGINEERED T CELLS WITH DISRUPTED CASITAS B-LINEAGE LYM...
- Publication number 20230346836
- Publication date Nov 2, 2023
- CRISPR Therapeutics AG
- Changan GUO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MATERIALS AND METHODS FOR TREATMENT OF FRIEDREICH ATAXIA AND OTHER...
- Publication number 20230330270
- Publication date Oct 19, 2023
- CRISPR Therapeutics AG
- Ante Sven Lundberg
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-CD83 CAR-T CELLS WITH REGNASE-1 AND/OR TGFBRII DISRUPTION
- Publication number 20230331841
- Publication date Oct 19, 2023
- CRISPR Therapeutics AG
- Daniel Robert HOSTETTER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
UNIVERSAL DONOR CELLS
- Publication number 20230323309
- Publication date Oct 12, 2023
- CRISPR Therapeutics AG
- Alireza Rezania
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-CD19 CAR-T CELLS WITH MULTIPLE GENE EDITS AND THERAPEUTIC USES...
- Publication number 20230303713
- Publication date Sep 28, 2023
- CRISPR Therapeutics AG
- Mohammed Ghonime
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MATERIALS AND METHODS FOR ENGINEERING CELLS AND USES THEREOF IN IMM...
- Publication number 20230302053
- Publication date Sep 28, 2023
- CRISPR Therapeutics AG
- Jonathan Alexander Terrett
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS AND COMPOSITIONS FOR TREATING LIPOPROTEIN-RELATED DISEASES
- Publication number 20230293646
- Publication date Sep 21, 2023
- CRISPR Therapeutics AG
- Sanjay D'Souza
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GENE EDITING FOR HEMOPHILIA A WITH IMPROVED FACTOR VIII EXPRESSION
- Publication number 20230285597
- Publication date Sep 14, 2023
- CRISPR Therapeutics AG
- Alan Richard Brooks
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS AND COMPOSITIONS FOR TREATING ANGIOPOIETIN-LIKE 3 (ANGPTL3)...
- Publication number 20230279376
- Publication date Sep 7, 2023
- CRISPR Therapeutics AG
- Yi-Shan Chen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GENETICALLY ENGINEERED T CELLS WITH REGNASE-1 AND/OR TGFBRII DISRUP...
- Publication number 20230263828
- Publication date Aug 24, 2023
- CRISPR Therapeutics AG
- Mary-Lee Dequeant
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
UNIVERSAL DONOR CELLS
- Publication number 20230250448
- Publication date Aug 10, 2023
- CRISPR Therapeutics AG
- Alireza Rezania
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GENE-EDITED NATURAL KILLER CELLS
- Publication number 20230227532
- Publication date Jul 20, 2023
- CRISPR Therapeutics AG
- Valentin SLUCH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HIGH PURITY gRNA SYNTHESIS PROCESS
- Publication number 20230220379
- Publication date Jul 13, 2023
- CRISPR Therapeutics AG
- Rajat Das
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GENETICALLY ENGINEERED T CELLS EXPRESSING BCMA-SPECIFIC CHIMERIC AN...
- Publication number 20230220059
- Publication date Jul 13, 2023
- CRISPR Therapeutics AG
- Jonathan Alexander TERRETT
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
UNIVERSAL DONOR CELLS
- Publication number 20230193209
- Publication date Jun 22, 2023
- CRISPR Therapeutics AG
- Alireza Rezania
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
UNIVERSAL DONOR CELLS
- Publication number 20230193210
- Publication date Jun 22, 2023
- CRISPR Therapeutics AG
- Alireza Rezania
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
UNIVERSAL DONOR CELLS
- Publication number 20230193313
- Publication date Jun 22, 2023
- CRISPR Therapeutics AG
- Alireza Rezania
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Please log in for detailed analytics

Trademarklast 30 trademarks

Information Trademark
98589124 - CTX450
- Serial number 98589124
- Filing date Jun 6, 2024
- CRISPR Therapeutics AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98589121 - CTX340
- Serial number 98589121
- Filing date Jun 6, 2024
- CRISPR Therapeutics AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98347437 - CTX211
- Serial number 98347437
- Filing date Jan 8, 2024
- CRISPR Therapeutics AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98247548 - CRISPR-X
- Serial number 98247548
- Filing date Oct 31, 2023
- CRISPR Therapeutics AG
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
98164704 - CRISPR THERAPEUTICS
- Serial number 98164704
- Filing date Sep 5, 2023
- CRISPR Therapeutics AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98164705 - CRISPR THERAPEUTICS
- Serial number 98164705
- Filing date Sep 5, 2023
- CRISPR Therapeutics AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
97828587 - CRISPRX
- Serial number 97828587
- Filing date Mar 8, 2023
- CRISPR Therapeutics AG
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
97828604 - CRISPRX
- Serial number 97828604
- Filing date Mar 8, 2023
- CRISPR Therapeutics AG
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
97635372 - DE&I IT'S IN OUR DNA
- Serial number 97635372
- Filing date Oct 17, 2022
- CRISPR Therapeutics AG
- 41 - Education
Information Trademark
97635364 - DIVERSITY, EQUITY, AND INCLUSION IT'S IN OUR DNA
- Serial number 97635364
- Filing date Oct 17, 2022
- CRISPR Therapeutics AG
- 41 - Education
Information Trademark
97635376 - CRISPR THERAPEUTICS DE&I IT'S IN OUR DNA DIVERSITY, EQUI...
- Serial number 97635376
- Filing date Oct 17, 2022
- CRISPR Therapeutics AG
- 41 - Education
Information Trademark
97635380 - CRISPR THERAPEUTICS DE&I IT'S IN OUR DNA. DIVERSITY, EQU...
- Serial number 97635380
- Filing date Oct 17, 2022
- CRISPR Therapeutics AG
- 41 - Education
Information Trademark
97635360 - CTX130
- Serial number 97635360
- Filing date Oct 17, 2022
- CRISPR Therapeutics AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
97558002 - CRISPRX
- Serial number 97558002
- Filing date Aug 22, 2022
- CRISPR Therapeutics AG
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
97469034 - CTX330
- Serial number 97469034
- Filing date Jun 21, 2022
- CRISPR Therapeutics AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
97461218 - CTX320
- Serial number 97461218
- Filing date Jun 16, 2022
- CRISPR Therapeutics AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
97461207 - CTX121
- Serial number 97461207
- Filing date Jun 16, 2022
- CRISPR Therapeutics AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
97461144 - VCTX212
- Serial number 97461144
- Filing date Jun 16, 2022
- CRISPR Therapeutics AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
97461217 - CTX310
- Serial number 97461217
- Filing date Jun 16, 2022
- CRISPR Therapeutics AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
97459047 - VCTX211
- Serial number 97459047
- Filing date Jun 15, 2022
- CRISPR Therapeutics AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
97459070 - VCTX211-DF
- Serial number 97459070
- Filing date Jun 15, 2022
- CRISPR Therapeutics AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
97459057 - PEC-211
- Serial number 97459057
- Filing date Jun 15, 2022
- CRISPR Therapeutics AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
97459065 - VCTX211-ST
- Serial number 97459065
- Filing date Jun 15, 2022
- CRISPR Therapeutics AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
97371557 - VCTX210
- Serial number 97371557
- Filing date Apr 20, 2022
- CRISPR Therapeutics AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
97371562 - CTX112
- Serial number 97371562
- Filing date Apr 20, 2022
- CRISPR Therapeutics AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
97371566 - CTX131
- Serial number 97371566
- Filing date Apr 20, 2022
- CRISPR Therapeutics AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
90722349 - COBALT
- Serial number 90722349
- Filing date May 19, 2021
- CRISPR Therapeutics AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
90715256 - CRISPR THERAPEUTICS
- Serial number 90715256
- Registration number 6724517
- Filing date May 17, 2021
- CRISPR Therapeutics AG
- 41 - Education
Information Trademark
90696824 - AVOLANCHE
- Serial number 90696824
- Filing date May 7, 2021
- CRISPR Therapeutics AG
- 9 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments
Information Trademark
90696814 - AVOLANCHE
- Serial number 90696814
- Filing date May 7, 2021
- CRISPR Therapeutics AG
- 9 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments

Crispr Therapeutics AG

Organization

Ticker Symbols

Business Address

Mailing Address

State Location

State of Incorporation

Patents Grantslast 30 patents

Materials and methods for controlling gene editing

Materials and methods for treatment of usher syndrome type 2A and/o...

Methods and compositions for treating angiopoietin-like 3 (ANGPTL3)...

Gene editing for hemophilia A with improved factor VIII expression

Compositions and methods for the depletion of CD117+ cells

Masked chimeric antigen receptor specific to tyrosine-protein kinas...

Compositions and methods for gene editing

Materials and methods for treatment of glycogen storage disease typ...

Genetically engineered T cells with Regnase-1 and/or TGFBRII disrup...

Materials and methods for treatment of alpha-1 antitrypsin deficiency

Methods and compositions for efficient gene deletion

Compositions and methods for genomic editing by insertion of donor...

Anti-idiotype antibodies targeting anti-CD70 chimeric antigen receptor

Genetically engineered t cells with Regnase-1 and/or TGFBRII disrup...

Genetically engineered T cells with regnase-1 and/or TGFBRII disrup...

Methods and compositions for treating cancer

Materials and methods for engineering cells and uses thereof in imm...

Gene-edited natural killer cells

Universal donor cells

RNA-programmable endonuclease systems and their use in genome editi...

Materials and methods for treatment of friedreich ataxia and other...

Universal donor cells

Materials and methods for treatment of Spinocerebellar Ataxia Type...

Gene editing for hemophilia A with improved factor VIII expression

Genetically engineered t cells with regnase-1 and/or TGFBRII disrup...

Compositions and methods for differentiating stem cells into NK cells

Materials and methods for engineering cells and uses thereof in imm...

Gene-edited natural killer cells

Universal donor cells

Universal donor cells

Patents Applicationslast 30 patents

GENE EDITING FOR HEMOPHILIA A WITH IMPROVED FACTOR VIII EXPRESSION

COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD117+ CELLS

MASKED CHIMERIC ANTIGEN RECEPTOR SPECIFIC TO TYROSINE-PROTEIN KINAS...

COMPOSITIONS AND METHODS FOR GENE EDITING

MATERIALS AND METHODS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE TYP...

MATERIALS AND METHODS FOR TREATMENT OF ALPHA-1 ANTITRYPSIN DEFICIENCY

COMPOSITIONS AND METHODS FOR GENE EDITING FOR HEMOPHILIA A

COMPOSITIONS AND METHODS FOR GENOMIC EDITING BY INSERTION OF DONOR...

GENETICALLY ENGINEERED ANTI-CD19 CAR-T CELLS FOR USE IN TREATING B-...

LIPID NANOPARTICLES (LNPs)-BASED OCULAR DELIVERY

MATERIALS AND METHODS FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS

MULTIPLEX GENE EDITED CELLS FOR CD70-DIRECTED CANCER IMMUNOTHERAPY

CD70+ SOLID TUMOR THERAPY USING GENETICALLY ENGINEERED T CELLS TARG...

GENETICALLY ENGINEERED T CELLS WITH DISRUPTED CASITAS B-LINEAGE LYM...

MATERIALS AND METHODS FOR TREATMENT OF FRIEDREICH ATAXIA AND OTHER...

ANTI-CD83 CAR-T CELLS WITH REGNASE-1 AND/OR TGFBRII DISRUPTION

UNIVERSAL DONOR CELLS

ANTI-CD19 CAR-T CELLS WITH MULTIPLE GENE EDITS AND THERAPEUTIC USES...

MATERIALS AND METHODS FOR ENGINEERING CELLS AND USES THEREOF IN IMM...

METHODS AND COMPOSITIONS FOR TREATING LIPOPROTEIN-RELATED DISEASES

GENE EDITING FOR HEMOPHILIA A WITH IMPROVED FACTOR VIII EXPRESSION

METHODS AND COMPOSITIONS FOR TREATING ANGIOPOIETIN-LIKE 3 (ANGPTL3)...

GENETICALLY ENGINEERED T CELLS WITH REGNASE-1 AND/OR TGFBRII DISRUP...

UNIVERSAL DONOR CELLS

GENE-EDITED NATURAL KILLER CELLS

HIGH PURITY gRNA SYNTHESIS PROCESS

GENETICALLY ENGINEERED T CELLS EXPRESSING BCMA-SPECIFIC CHIMERIC AN...

UNIVERSAL DONOR CELLS

UNIVERSAL DONOR CELLS

UNIVERSAL DONOR CELLS

Trademarklast 30 trademarks

98589124 - CTX450

98589121 - CTX340

98347437 - CTX211

98247548 - CRISPR-X

98164704 - CRISPR THERAPEUTICS

98164705 - CRISPR THERAPEUTICS

97828587 - CRISPRX

97828604 - CRISPRX

97635372 - DE&I IT'S IN OUR DNA

97635364 - DIVERSITY, EQUITY, AND INCLUSION IT'S IN OUR DNA